P950: COMBINED PROTEASOME AND AUTOPHAGY INHIBITION IN RELAPSED/REFRACTORY MULTIPLE MYELOMA – A PHASE I TRIAL OF HYDROXYCHLOROQUINE, CARFILZOMIB AND DEXAMETHASONE

• T. S. Slørdahl,
• F. B. Askeland,
• M. S. S. Hanssen,
• S. M. Sundt-Hansen,
• N. T. Vethe,
• H. Hjorth-Hansen,
• M. H. Fenstad,
• A. Waage,
• Ø. Hjertner,
• F. Schjesvold,
• A. Sundan

Affiliations

T. S. Slørdahl

1 Department of Hematology, St. Olavs Hospital

F. B. Askeland

3 Oslo Myeloma Center, Department of Hematology, Oslo University Hospital

M. S. S. Hanssen

5 Department of Ophthalmology, St. Olavs Hospital, Trondheim

S. M. Sundt-Hansen

1 Department of Hematology, St. Olavs Hospital

N. T. Vethe

6 Department of Pharmacology, Oslo University Hospital, Oslo

H. Hjorth-Hansen

1 Department of Hematology, St. Olavs Hospital

M. H. Fenstad

7 Department of Immunology and Transfusion Medicine, St. Olavs Hospital, Trondheim, Norway

A. Waage

2 Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim

Ø. Hjertner

1 Department of Hematology, St. Olavs Hospital

F. Schjesvold

3 Oslo Myeloma Center, Department of Hematology, Oslo University Hospital

A. Sundan

2 Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim